Cemex (NYSE:CX) reported quarterly sales of $4.08 billion which beat the analyst consensus estimate of $3.73 billion by 9.38 percent. This is a 5.84 percent increase over sales of $3.85 billion the same period last year.
P/E Ratio Insights for Horizon Therapeutics
In the current session, the stock is trading at $113.00, after a 0.36% increase. Over the past month,…